跳至主要内容
临床试验/JPRN-UMIN000024397
JPRN-UMIN000024397尚未招募未知

Efficacy and safety of oral immunotherapy combination with omalizumab for severe cow's milk allergy- follow up study- - Oral immunotherapy combination with omalizumab for severe cow's milk allergy- follow up study

Kansai Medical University0 个研究点目标入组 15 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6years-old 至 15years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Children who have acute disease and chronic disease except allergic disease. 2.Children or guardian who deny the study 3. Children who were judged as inappropriate by the study director

研究者

相似试验